bpc-157 human studies safety adverse effects trials BPC-157 and the Difference Between an Evidence Gap BPC-157 for athletes and injury
Description
Concurrent administration of pyridoxine with these medications has been reported to lower their therapeutic levels, so monitoring and dosage adjustments of the anticonvulsant might be required if high-dose vitamin B is given

With neurological symptoms: 1000 g intramuscularly on alternate days should be continued for up to three weeks or until there is no further improvement
Research-use-only means the compound is sold strictly for laboratory or analytical research and is not approved for human or veterinary use

Knowing what triggers it helps doctors diagnose and treat it early
